Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001377121-17-000003
Filing Date
2017-05-10
Accepted
2017-05-10 16:12:49
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx10-qq12017.htm 10-Q 1032489
2 EXHIBIT 31.1 ptgx10-qq1ex311.htm EX-31.1 14138
3 EXHIBIT 31.2 ptgx10-qq1ex312.htm EX-31.2 14150
4 EXHIBIT 32.1 ptgx10-qq1ex321.htm EX-32.1 11719
  Complete submission text file 0001377121-17-000003.txt   4511792

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptgx-20170331.xml EX-101.INS 779703
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptgx-20170331.xsd EX-101.SCH 40037
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptgx-20170331_cal.xml EX-101.CAL 58893
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptgx-20170331_def.xml EX-101.DEF 179606
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptgx-20170331_lab.xml EX-101.LAB 498029
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptgx-20170331_pre.xml EX-101.PRE 292377
Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 17830368
SIC: 2834 Pharmaceutical Preparations